Patents by Inventor Soondong Lee

Soondong Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220347244
    Abstract: A recombinant vaccinia virus containing a gene encoding sPD-1 or hyaluronidase and a pharmaceutical composition including the same are disclosed. The recombinant vaccinia virus containing a cancer therapy gene and having suppressed expression of K3L, TK, or VGF gene of the vaccinia virus has an excellent anti-tumor effect. Therefore, the recombinant vaccinia virus of the present invention can be advantageously used in cancer treatment.
    Type: Application
    Filed: January 18, 2019
    Publication date: November 3, 2022
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Heonsik CHOI, Minjung KIM, Jaeil SHIN, Soonoh HONG, Hyesun LEE, Soondong LEE, Hwanjun CHOI, Joonsung KIM, Jieun HONG, Eunjin LEE, Haesu KANG
  • Patent number: 11452770
    Abstract: The present invention relates to a recombinant vaccinia virus in which the expression of some genes is inhibited, and a use thereof. The recombinant vaccinia virus of the present invention selectively kills cancer cells, and has an excellent reproducibility in cancer cells. Also, the virus has a lower toxicity to normal cells, and thus has an advantage of being safe for a human body. Therefore, the recombinant vaccinia virus of the present invention can be effectively used as a composition for treating cancer.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: September 27, 2022
    Assignee: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong Kim, Minjung Kim, Heonsik Choi, Jaeil Shin, Minju Kim, Hyesun Lee, Soondong Lee, Hwanjun Choi, Joonsung Kim, Jieun Hong, Eunjin Lee
  • Patent number: 10508346
    Abstract: Disclosed is a pattern of a film layer including aluminum, and a manufacturing method and an aftertreatment method thereof. In the manufacturing method, a patterned photoresist layer (320) which covers on a to-be-patterned film layer (310) including aluminum is taken as a mask, and a dry etching process is performed on the to-be-patterned film layer (310) by using a gas including Cl2 to form a patterned film layer; and then the formed patterned film layer (310) including aluminum is subjected to dechlorination treatment and uninstalling of a bearing substrate (200) simultaneously. The method can improve the productivity and save the cost.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: December 17, 2019
    Assignees: BOE TECHNOLOGY GROUP CO., LTD., ORDOS YUANSHENG OPTOELECTRONICS CO., LTD.
    Inventors: Xiaodi Huo, Guote Wu, Soondong Lee, Jihoon Lee
  • Publication number: 20190255152
    Abstract: The present invention relates to a composition for alleviating or treating pain. A pharmaceutical composition of the present invention contains two or more selected from the group consisting of GAD, IL-10, and a gene encoding GDNF. The pharmaceutical composition of the present invention exhibits an excellent analgesic effect at a dosage lower than that of individual administration since genes are coadministered, and thus conventional side effects and toxicity can be reduced. Therefore, the pharmaceutical composition of the present invention can be useful in alleviating or treating pain.
    Type: Application
    Filed: October 31, 2017
    Publication date: August 22, 2019
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Heonsik CHOI, Yejin KWON, Minjung KIM, Minju KIM, Daewook KIM, Jangjoon PARK, Jongho CHO, Soondong LEE, Joonsung KIM, Yeomoon SIM
  • Publication number: 20190247487
    Abstract: The present invention relates to a recombinant vaccinia virus in which the expression of some genes is inhibited, and a use thereof. The recombinant vaccinia virus of the present invention selectively kills cancer cells, and has an excellent reproducibility in cancer cells. Also, the virus has a lower toxicity to normal cells, and thus has an advantage of being safe for a human body. Therefore, the recombinant vaccinia virus of the present invention can be effectively used as a composition for treating cancer.
    Type: Application
    Filed: July 21, 2017
    Publication date: August 15, 2019
    Applicant: KOLON LIFE SCIENCE, INC.
    Inventors: Sujeong KIM, Minjung KIM, Heonsik CHOI, Jaeil SHIN, Minju KIM, Hyesun LEE, Soondong LEE, Hwanjun CHOI, Joonsung KIM, Jieun HONG, Eunjin LEE
  • Publication number: 20190062925
    Abstract: Disclosed is a pattern of a film layer including aluminum, and a manufacturing method and an aftertreatment method thereof. In the manufacturing method, a patterned photoresist layer (320) which covers on a to-be-patterned film layer (310) including aluminum is taken as a mask, and a dry etching process is performed on the to-be-patterned film layer (310) by using a gas including Cl2 to form a patterned film layer; and then the formed patterned film layer (310) including aluminum is subjected to dechlorination treatment and uninstalling of a bearing substrate (200) simultaneously. The method can improve the productivity and save the cost.
    Type: Application
    Filed: August 10, 2017
    Publication date: February 28, 2019
    Inventors: Xiaodi Huo, Guote Wu, Soondong Lee, Jihoon Lee